Phase II Study Of Decitabine In Patients With Metastatic Papillary Thyroid Cancer Or Follicular Thyroid Cancer Unresponsive To Radioiodine.
Phase of Trial: Phase II
Latest Information Update: 29 Aug 2014
At a glance
- Drugs Decitabine (Primary) ; Fludeoxyglucose F-18; Iodine-131; Liothyronine; Thyrotropin alfa
- Indications Thyroid cancer
- Focus Therapeutic Use
- 27 Aug 2013 Planned end date changed from 1 Jan 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov.
- 01 Apr 2013 Status changed from suspended to active, no longer recruiting as reported by ClinicalTrials.gov.
- 02 Jan 2013 Status changed from active, no longer recruiting to suspended as reported by ClinicalTrials.gov.